Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059141) titled 'A Randomized Controlled Trial on Reducing Patient Anxiety and Predicting Heart Failure Exacerbation Using a Wearable Electrocardiogram Device' on Oct. 1.
Study Type: Interventional
Study Design:
Parallel Randomized
Primary Sponsor: Juntendo University
Condition:
Cardiac Diseases
Intervention:
The wearable ECG group will be provided with a wearable ECG device and a smartphone with a dedicated app installed. ECG data during daily life will be collected from immediately after discharge until noon the following day, one week later, and two weeks later. Additionally, spot measurements will be evaluated, such...